Cite
MLA Citation
Cheng-Chun Tai et al.. “Comparing Late-line Treatment Sequence of Regorafenib and Reduced-intensity FOLFOXIRI for Refractory Metastatic Colorectal Cancer.” American journal of clinical oncology, vol. 43, 2020, p. . http://access.bl.uk/ark:/81055/vdc_100131654226.0x000045